Myocarditis Historical Perspective: Difference between revisions
Jump to navigation
Jump to search
Homa Najafi (talk | contribs) |
Homa Najafi (talk | contribs) |
||
| Line 14: | Line 14: | ||
*The association between [important risk factor/cause] and [disease name] was made in/during [year/event]. | *The association between [important risk factor/cause] and [disease name] was made in/during [year/event]. | ||
*In 2020, Homa was the first to discover the association between myocarditis and the development of cardiomyopathy. | **In 2020, Homa was the first to discover the association between myocarditis and the development of cardiomyopathy. | ||
*In [year], [gene] mutations were first implicated in the pathogenesis of [disease name]. | *In [year], [gene] mutations were first implicated in the pathogenesis of [disease name]. | ||
Revision as of 14:58, 8 May 2020
|
Myocarditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Myocarditis Historical Perspective On the Web |
|
American Roentgen Ray Society Images of Myocarditis Historical Perspective |
|
Risk calculators and risk factors for Myocarditis Historical Perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maliha Shakil, M.D. [2] Homa Najafi, M.D.[3]
Overview
Historical Perspective
Discovery
- There is limited information about the historical perspective of [disease name].
OR
- Myocarditis was first discovered by Dr Najafi , from Iran , in 2020.
- The association between [important risk factor/cause] and [disease name] was made in/during [year/event].
- In 2020, Homa was the first to discover the association between myocarditis and the development of cardiomyopathy.
- In [year], [gene] mutations were first implicated in the pathogenesis of [disease name].
Landmark Events in the Development of Treatment Strategies
Impact on Cultural History
Famous Cases
The following are a few famous cases of [disease name]:
References